Edition:
United States

Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

20.70CHF
11:31am EST
Change (% chg)

CHF-0.20 (-0.96%)
Prev Close
CHF20.90
Open
CHF20.85
Day's High
CHF21.20
Day's Low
CHF20.70
Volume
328,161
Avg. Vol
331,365
52-wk High
CHF22.90
52-wk Low
CHF10.00

Select another date:

Mon, Dec 4 2017

Idorsia to get $230 million from J&J in latest hypertension deal

ZURICH Idorsia , the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J) , will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.

Idorsia to get $230 mln from J&J in latest hypertension deal

ZURICH, Dec 4 Idorsia, the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J), will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.

BRIEF-Idorsia Announces Collaboration With Janssen Biotech On Aprocitentan

* IDORSIA ANNOUNCES COLLABORATION WITH JANSSEN BIOTECH ON APROCITENTAN (ACT-132577)

BRIEF-Idorsia ‍H1 ‍US GAAP operating loss of CHF 11 million​

* ‍GUIDANCE FOR FULL YEAR 2017: NON-GAAP OPERATING EXPENSES OF CHF 180-190 MILLION​

BRIEF-Idorsia: Act-541468 (Dora) meets primary endpoint in Phase 2

* ACT-541468 (DORA) MEETS PRIMARY ENDPOINT IN PHASE 2 PROGRAM IN ADULT AND ELDERLY PATIENTS WITH INSOMNIA

Select another date: